InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
77.08
(
-0.14%
)
Bitcoin
59,138.98
(
0.03%
)
Post# of 94785
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

joenatural

Send PM Follow Ignore
Followers 657
Posts 24628
Boards Moderated 2
Alias Born 07/16/2006

joenatural

Re: BiotechValues post# 7517

Friday, 10/23/2009 3:31:58 PM

Friday, October 23, 2009 3:31:58 PM

Post# of 94785
The financing was back in the Spring, but the restatement of EPS last quarter was due to accounting reasons surrounding warrants, etc. This was all disclosed back on August 19th and it didn't stop the stock from reaching new highs and even these new recent highs are a pimple on the face of a giant. The raised guidance from yesterday indicates EPS of .92 for 2009 with 50% growth in revenues each year for the next three years .......

"Not knocking the stock..but wasn't three some dilution last q that caused a decline in eps just reported?"
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up